vs
Side-by-side financial comparison of LXP Industrial Trust (LXP) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
LXP Industrial Trust is the larger business by last-quarter revenue ($86.7M vs $83.1M, roughly 1.0× PROCEPT BioRobotics Corp). LXP Industrial Trust runs the higher net margin — 33.2% vs -38.1%, a 71.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -14.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 0.3%).
LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
LXP vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $86.7M | $83.1M |
| Net Profit | $28.8M | $-31.6M |
| Gross Margin | 81.5% | 64.9% |
| Operating Margin | 34.6% | -4.1% |
| Net Margin | 33.2% | -38.1% |
| Revenue YoY | -14.0% | 20.2% |
| Net Profit YoY | — | -27.9% |
| EPS (diluted) | — | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $86.7M | $76.4M | ||
| Q3 25 | $86.9M | $83.3M | ||
| Q2 25 | $87.7M | $79.2M | ||
| Q1 25 | $88.9M | $69.2M | ||
| Q4 24 | $100.9M | $68.2M | ||
| Q3 24 | $85.6M | $58.4M | ||
| Q2 24 | $85.8M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $28.8M | $-29.8M | ||
| Q3 25 | $36.3M | $-21.4M | ||
| Q2 25 | $29.1M | $-19.6M | ||
| Q1 25 | $19.0M | $-24.7M | ||
| Q4 24 | — | $-18.9M | ||
| Q3 24 | $6.3M | $-21.0M | ||
| Q2 24 | $5.4M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 81.5% | 60.6% | ||
| Q3 25 | 82.3% | 64.8% | ||
| Q2 25 | 81.9% | 65.4% | ||
| Q1 25 | 80.7% | 63.9% | ||
| Q4 24 | 85.3% | 64.0% | ||
| Q3 24 | 82.5% | 63.2% | ||
| Q2 24 | 82.0% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 34.6% | -40.6% | ||
| Q3 25 | 50.4% | -27.8% | ||
| Q2 25 | 33.7% | -28.0% | ||
| Q1 25 | 21.8% | -39.7% | ||
| Q4 24 | — | -28.9% | ||
| Q3 24 | 7.9% | -38.4% | ||
| Q2 24 | 6.9% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 33.2% | -39.1% | ||
| Q3 25 | 41.7% | -25.7% | ||
| Q2 25 | 33.2% | -24.7% | ||
| Q1 25 | 21.4% | -35.8% | ||
| Q4 24 | — | -27.6% | ||
| Q3 24 | 7.4% | -35.9% | ||
| Q2 24 | 6.3% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | — | $-0.54 | ||
| Q3 25 | $0.12 | $-0.38 | ||
| Q2 25 | $0.09 | $-0.35 | ||
| Q1 25 | $0.06 | $-0.45 | ||
| Q4 24 | — | $-0.34 | ||
| Q3 24 | $0.02 | $-0.40 | ||
| Q2 24 | $0.01 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $170.4M | $245.6M |
| Total DebtLower is stronger | $1.4B | $51.7M |
| Stockholders' EquityBook value | $2.0B | $347.7M |
| Total Assets | $3.5B | $487.1M |
| Debt / EquityLower = less leverage | 0.66× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $170.4M | $286.5M | ||
| Q3 25 | $229.7M | $294.3M | ||
| Q2 25 | $71.0M | $302.7M | ||
| Q1 25 | $70.9M | $316.2M | ||
| Q4 24 | $101.8M | $333.7M | ||
| Q3 24 | $55.0M | $196.8M | ||
| Q2 24 | $48.7M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $1.4B | $51.6M | ||
| Q3 25 | $1.5B | $51.6M | ||
| Q2 25 | $1.5B | $51.5M | ||
| Q1 25 | $1.5B | $51.5M | ||
| Q4 24 | $1.6B | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $2.0B | $365.9M | ||
| Q3 25 | $2.1B | $380.3M | ||
| Q2 25 | $2.1B | $385.8M | ||
| Q1 25 | $2.1B | $389.2M | ||
| Q4 24 | $2.1B | $402.2M | ||
| Q3 24 | $2.1B | $241.2M | ||
| Q2 24 | $2.1B | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $3.5B | $508.1M | ||
| Q3 25 | $3.7B | $511.5M | ||
| Q2 25 | $3.7B | $513.1M | ||
| Q1 25 | $3.8B | $519.4M | ||
| Q4 24 | $3.8B | $534.0M | ||
| Q3 24 | $3.9B | $374.1M | ||
| Q2 24 | $3.9B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.66× | 0.14× | ||
| Q3 25 | 0.72× | 0.14× | ||
| Q2 25 | 0.72× | 0.13× | ||
| Q1 25 | 0.73× | 0.13× | ||
| Q4 24 | 0.75× | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $188.7M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 6.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $188.7M | $-10.3M | ||
| Q3 25 | $63.5M | $-6.6M | ||
| Q2 25 | $44.3M | $-15.0M | ||
| Q1 25 | $39.0M | $-17.0M | ||
| Q4 24 | $211.2M | $-32.4M | ||
| Q3 24 | $64.6M | $-18.8M | ||
| Q2 24 | $38.5M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-9.5M | ||
| Q2 25 | — | $-17.8M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-19.0M | ||
| Q2 24 | — | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | — | -22.5% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | — | -49.2% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | — | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 6.56× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 2.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.18× | — | ||
| Q2 24 | 7.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LXP
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
